• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Genentech

Genentech

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Phase III Study Showed Genentech ’s Cancer Immunotherapy TECENTRIQ™ (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy

    Phase III Study Showed Genentech ’s Cancer Immunotherapy TECENTRIQ™ (Atezolizumab) Helped People with a Specific Type of Lung Cancer Live Significantly Longer Compared to Chemotherapy

  2. Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022 - Research and Markets

    Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022 - Research and Markets

  3. Exelixis Provides Update on Timing of Key Cabozantinib Clinical Data Presentation at the ESMO 2016 Congress

    Exelixis Provides Update on Timing of Key Cabozantinib Clinical Data Presentation at the ESMO 2016 Congress

  4. Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022 - Research and Markets

    Global Pancreatic Beta-Cell Protection Market Analysis 2016 - Forecast to 2022 - Research and Markets

  5. Symphogen Names New Chief Financial Officer

    Symphogen Names New Chief Financial Officer

  6. Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

    Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

  7. Phase III Efficacy Results of Investigational Medicine OCREVUS™ (Ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis

    Phase III Efficacy Results of Investigational Medicine OCREVUS™ (Ocrelizumab) Reinforced by Exploratory Analyses in Two Forms of Multiple Sclerosis

  8. Invitation to Cover: Major New Initiative to Defeat Pediatric Brain Tumors to be Announced at National Press Club

    Invitation to Cover: Major New Initiative to Defeat Pediatric Brain Tumors to be Announced at National Press Club

  9. Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight - Research and Markets

    Global Cancer Angiogenesis Inhibitors Market & Clinical Pipeline Insight - Research and Markets

  10. Alzheimer's Drugs Market Analysis: By Phase, Drug Type & Geography - Forecast to 2021 - Research and Markets

    Alzheimer's Drugs Market Analysis: By Phase, Drug Type & Geography - Forecast to 2021 - Research and Markets

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.